Skip to main content
. Author manuscript; available in PMC: 2018 Oct 1.
Published in final edited form as: Schizophr Res. 2017 Jan 25;188:141–143. doi: 10.1016/j.schres.2017.01.028

Table 1.

Descriptive statistics between baseline and post-intervention treatment arms for computerized vocal and facial measures.

Pre-Treatment Post-Treatment Condition F Treatment F Interaction F Cohen’s da
Vocal: Pause times
 Placebo 2694.19 (1486.06) 2611.03 (1554.43) 0.67 0.76 0.67 −0.05
 Oxytocin 2303.19 (1306.69) 1958.76 (1150.16) −0.28
 Galantamine 2434.51 (1049.42) 2300.88 (951.35) −0.13
Vocal: Intonation
 Placebo 2.22 (0.87) 1.87 (0.48) 2.15 2.04 2.15 −0.52
 Oxytocin 2.53 (1.30) 1.93 (0.63) −0.62
 Galantamine 2.51 (1.17) 2.67 (0.84) 0.16
Vocal: Emphasis
 Placebo 4.32 (3.93) 3.07 (1.23) 2.05 0.26 2.05 −0.48
 Oxytocin 4.84 (4.34) 3.54 (0.96) −0.49
 Galantamine 4.02 (1.70) 4.01 (1.31) −0.01
Facial: Neutral
 Placebo 0.32 (0.11) 0.30 (0.15) 0.06 0.06 0.06 −0.15
 Oxytocin 0.32 (0.15) 0.33 (0.19) 0.06
 Galantamine 0.32 (0.13) 0.31 (0.12) −0.08
Facial: Happy
 Placebo 0.08 (0.09) 0.12 (0.11) 0.14 0.68 0.40
 Oxytocin 0.06 (0.08) 0.07 (0.10) 0.14 0.11
 Galantamine 0.10 (0.11) 0.08 (0.09) −0.20
Facial: Negative
 Placebo 0.16 (0.13) 0.16 (0.13) 1.10 0.08 1.10 0.00
 Oxytocin 0.14 (0.11) 0.20 (0.10) 0.57
 Galantamine 0.16 (0.13) 0.18 (0.12) 0.16
a

d values computed pre to post within each treatment arm.